These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8892210)
1. Measurement of Gd-DTPA dialysis clearance rates by using a look-locker imaging technique. Niendorf ER; Santyr GE; Brazy PC; Grist TM Magn Reson Med; 1996 Oct; 36(4):571-8. PubMed ID: 8892210 [TBL] [Abstract][Full Text] [Related]
2. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Choyke PL; Austin HA; Frank JA; Girton ME; Diggs RL; Dwyer AJ; Miller L; Nussenblatt R; McFarland H; Simon T Kidney Int; 1992 Jun; 41(6):1595-8. PubMed ID: 1501414 [TBL] [Abstract][Full Text] [Related]
3. Rapid measurement of Gd-DTPA extraction fraction in a dialysis system using echo-planar imaging. Niendorf ER; Grist TM; Frayne R; Brazy PC; Santyr GE Med Phys; 1997 Dec; 24(12):1907-13. PubMed ID: 9434973 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate. Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583 [TBL] [Abstract][Full Text] [Related]
5. Clearance of gadolinium chelates by hemodialysis: an in vitro study. Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
8. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive measurement of renal hemodynamic functions using gadolinium enhanced magnetic resonance imaging. Dumoulin CL; Buonocore MH; Opsahl LR; Katzberg RW; Darrow RD; Morris TW; Batey C Magn Reson Med; 1994 Sep; 32(3):370-8. PubMed ID: 7984069 [TBL] [Abstract][Full Text] [Related]
10. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Diesbourg LD; Prato FS; Wisenberg G; Drost DJ; Marshall TP; Carroll SE; O'Neill B Magn Reson Med; 1992 Feb; 23(2):239-53. PubMed ID: 1549039 [TBL] [Abstract][Full Text] [Related]
11. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat. Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H] J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117 [TBL] [Abstract][Full Text] [Related]
12. Elimination of gadolinium-DTPA by peritoneal dialysis. Dörsam J; Knopp MV; Schad L; Piesche S; Carl S; Oesingmann N Nephrol Dial Transplant; 1995; 10(7):1228-30. PubMed ID: 7478129 [TBL] [Abstract][Full Text] [Related]
14. Relaxation of solvent protons by solute Gd3+-chelates revisited. Kellar KE; Henrichs PM; Spiller M; Koenig SH Magn Reson Med; 1997 May; 37(5):730-5. PubMed ID: 9126947 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190 [TBL] [Abstract][Full Text] [Related]
16. Gadopentetate dimeglumine as a marker of renal function. Magnetic resonance imaging to glomerular filtration rates. Frank JA; Choyke PL; Austin HA; Girton ME; Weiss G Invest Radiol; 1991 Nov; 26 Suppl 1():S134-6; discussion S137-8. PubMed ID: 1808110 [No Abstract] [Full Text] [Related]
17. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Pereira RS; Prato FS; Wisenberg G; Sykes J Magn Reson Med; 1996 Nov; 36(5):684-93. PubMed ID: 8916018 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
19. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [TBL] [Abstract][Full Text] [Related]
20. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Tong CY; Prato FS; Wisenberg G; Lee TY; Carroll E; Sandler D; Wills J Magn Reson Med; 1993 Sep; 30(3):332-6. PubMed ID: 8412604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]